Whole coffee fruit extract,
does it really help with Improvement in BDNF, focus, and memory?
research showsWhole coffee fruit extract improved blood BDNF and some working-memory and response-inhibition measures in small trials. BDNF is a surrogate that cannot stand in for clinical cognitive improvement, however, and every identified single-ingredient trial was linked to the ingredient company through support or conflicts of interest, yielding C.
ads claimClaims of '143% higher BDNF' and 'better focus and memory' combine a single-dose blood biomarker with selected computerized tasks. Dementia prevention and everyday memory improvement were not directly tested.
Useful facts when choosing a product
- Proprietary-ingredient studies generally used 100-200 mg/day.
- Plasma or exosomal BDNF is not equivalent to clinical memory improvement.
- Single-ingredient studies must be distinguished from phosphatidylserine combinations.
- Key single-ingredient trials included manufacturer support or author conflicts.
Chamgap Semantic Classification Code
Candidate index · review held
S.whole-coffee-fruit-extract.UNK.bdnf-focus-and-memory.improve.placeboSupplements and nutraceuticals > Whole coffee fruit extract > Unknown > BDNF, focus, and memory > Improvement claim > Placebo
An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.
What the research actually shows
The Reyes-Izquierdo 2013 trial reported increased plasma BDNF after a single 100 mg dose in 10 healthy participants. The Robinson 2021 crossover trial in eight older adults reported changes in BDNF, functional connectivity, and some reaction-time measures after 100 mg. The Robinson 2024 randomized trial reported improvements in selected working-memory and response-inhibition accuracy measures with 200 mg, but it was ingredient-company sponsored. A combined whole coffee cherry and phosphatidylserine trial cannot isolate this ingredient.
Why this is classified as C (45)
Human randomized trials and repeated signals rule out an unknown or D grade. Because all positive single-ingredient evidence is manufacturer-concentrated and centers on BDNF and brief tasks, the grade is capped at C; lack of independent replication yields 47 points.
Counterpoint. Repeated working-memory and response-inhibition signals remain. This verdict does not extend them to durable memory improvement or prevention of cognitive disease.
Rejudgment record. New verdict — Randomized-trial signals, but all positive single-ingredient evidence is manufacturer-linked and centered on BDNF surrogates and brief cognitive tasks
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Increase in blood BDNF | C | It increased in small single-dose trials, but it is a surrogate and the evidence is manufacturer-concentrated. |
| Improvement in focus and memory | C | Some working-memory and response-inhibition tasks were positive, but everyday memory and long-term outcomes remain untested. |
Cross-check — AI research and Codex final gate
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Reyes-Izquierdo T et al. 2013 | Randomized single-dose controlled trial | 10 | Supported by FutureCeuticals | Plasma BDNF | BDNF increased after one 100 mg dose; clinical cognition was not assessed. | Supportive |
| Robinson JL et al. 2021 | Randomized double-blind placebo-controlled crossover trial | 8 | FutureCeuticals support and employee coauthors | BDNF, neuroimaging, and cognitive tasks | Signals in BDNF and selected neurophysiological and reaction-time measures; extremely small sample. | Key |
| Robinson JL et al. 2024 | Remote randomized double-blind placebo-controlled trial | 323 | FutureCeuticals sponsored with author conflicts | Working memory and response inhibition | Some acute and longitudinal accuracy measures improved with 200 mg; not clinical outcomes. | Key |
Receipt — 3 References
All 3 cited sources were verified for existence at the original page (as of 2026-07-11).
Final verification and publication gate: Codex · Evidence date: 2026-07-11 · Corrections: none
Cite this verdict
[Chamgap] Whole coffee fruit extract (NeuroFactor/CognatiQ) x improvement in BDNF, focus, and memory — Evidence Grade C·45. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/cognition/whole-coffee-fruit-bdnf-cognition/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.